Watch VANI. Know when insiders buy.
One email the day a filing lands. Free.
VANI
Vivani Medical, Inc.
1.23
+0.01 +0.82%
USD · close Oct 2
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
68
PASS · shorts 68
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $111MP/E —DIV YIELD —FCF YIELD -23.88%REV TTM —NET INCOME −$26.3MNET CASH $17.7M52W 0.94 – 1.87SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$6.9M | −$6.4M | — | -0.07 | −$6M | $99K | −$6.1M | Aug 13 |
| Q1 2026 · Mar 31 | — | — | — | −$6.8M | −$6.8M | — | -0.08 | −$6.2M | $3K | −$6.2M | Aug 13 |
| Q4 2025 · Dec 31derived | — | — | — | −$6.8M | −$6.6M | — | -0.09 | −$6.7M | $274K | −$7M | Mar 26 |
| Q3 2025 · Sep 30 | — | — | — | −$6.7M | −$6.5M | — | -0.11 | −$6.4M | $823K | −$7.2M | Nov 13 |
| Q2 2025 · Jun 30 | — | — | — | −$7.5M | −$7.1M | — | -0.12 | −$6.1M | $71K | −$6.2M | Aug 13 |
| Q1 2025 · Mar 31 | — | — | — | −$6.6M | −$6.3M | — | -0.11 | −$5.2M | $5K | −$5.2M | Aug 13 |
| Q4 2024 · Dec 31derived | — | — | — | −$6.5M | −$6M | — | -0.11 | −$5.8M | $296K | −$6.1M | Mar 26 |
| Q3 2024 · Sep 30 | — | — | — | −$6.3M | −$6M | — | -0.11 | −$5.7M | $41K | −$5.7M | Nov 13 |
| Q2 2024 · Jun 30 | — | — | — | −$5.7M | −$5.4M | — | -0.10 | −$4.8M | $37K | −$4.8M | Nov 13 |
| Q1 2024 · Mar 31 | — | — | — | −$6.2M | −$6M | — | -0.12 | −$4.5M | $182K | −$4.7M | Nov 13 |
| Q4 2023 · Dec 31derived | — | — | — | −$6.2M | −$6M | — | -0.11 | −$3.5M | $743K | −$4.2M | Mar 31 |
| Q3 2023 · Sep 30 | — | — | — | −$7.1M | −$6.8M | — | -0.13 | −$7.7M | $63K | −$7.8M | Nov 13 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$27.6M | −$26.6M | — | -0.43 | −$24.3M | $1.2M | −$25.5M | — | — |
| FY2024 · to Dec 31 | — | — | −$24.7M | −$23.5M | — | -0.43 | −$20.8M | $556K | −$21.3M | — | — |
| FY2023 · to Dec 31 | — | — | −$27M | −$25.7M | — | -0.50 | −$23.7M | $887K | −$24.6M | — | — |
| FY2022 · to Dec 31 | — | — | −$21.2M | −$13.9M | — | — | −$18.8M | $338K | −$19.1M | — | — |
| FY2021 · to Dec 31 | — | — | −$13.3M | −$12.8M | — | -0.27 | −$11M | $572K | −$11.5M | — | — |
| FY2020 · to Dec 31 | — | — | −$14.9M | −$14.9M | — | -0.72 | −$16.8M | $330K | −$17.2M | — | — |
Every number comes from Vivani Medical, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.